跳至主要内容
临床试验/NCT03090399
NCT03090399已完成不适用

Effects of the Goal-directed Fluid Therapy on ASA 1 Patients Scheduled for Intensive Debulking Surgery

Fondazione Policlinico Universitario Agostino Gemelli IRCCS0 个研究点目标入组 60 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
主要终点
prevalence of complications

研究概览

简要总结

In this retrospective analysis investigators will study the effects of using a minimally invasive hemodynamic monitoring (FloTrac-Edwards) on postoperative outcomes. Participants will compare a control group to a case group; in both groups ASA 1 patients suffering from advanced ovarian cancer underwent radical cytoreductive surgery. In case group hemodynamic was managed by using the FloTrac system; in the control group a standard hemodynamic monitoring was used.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • cardiac diseases
  • pulmonary diseases
  • renal diseases
  • metabolic disorders

结局指标

主要结局

prevalence of complications

时间窗: up to 30 days

次要结局

  • days of hospitalization(up to 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr.Andrea Russo

Medical Doctor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

相似试验

Fluid ORiented Therapy for yoUNg Asa 1patients | 临床试验